ALFA Filings
Every announcement, straight from the exchange
Every Entero Healthcare Solutions earnings call announcement on NSE and BSE, newest first, each with its own page.
Time
5 announcements with these filters
Entero delivered a strong Q1 FY27 with 38.2% revenue growth and hit its full-year EBITDA margin target of 5% in the first quarter itself, signaling rapid structural margin expansion.
Q1FY27 revenue grew 38.2% YoY to ₹1,940.5 Cr with significant margin expansion. Strategy focuses on MedTech scaling and consolidating India's fragmented pharmaceutical distribution market.
Entero delivered solid FY26 results, meeting all guidance parameters. Management transitions focus toward organic growth and margin expansion through technology-led scaling and higher-margin MedTech distribution.
Entero Healthcare delivered on its FY26 guidance with 31.5% like-for-like revenue growth and 4% EBITDA margins. Management transitioned to organic growth and profitability, focusing on higher-margin MedTech segments.
Entero delivered strong FY26 performance meeting all guidance parameters. Revenue grew 29.3% to ₹6,591 Cr with EBITDA margins expanding to 4.0%, driven by organic growth and 7 strategic acquisitions.